⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EDIT News
Editas Medicine, Inc. Common Stock
U.S. CAR T-Cell Therapies Market Grows at 30.4% CAGR, Soars USD 42.61 Billion by 2035
globenewswire.com
BIIB
GILD
BMY
ABBV
MRNA
CRSP
NTLA
EDIT
Cassidy Bio Launches with the Goal to Develop Safer, More Scalable Gene Editing Therapies
businesswire.com
EDIT
NTLA
BMY
AZN
Editas Medicine Announces Third Quarter 2025 Results and Business Updates
globenewswire.com
EDIT
Editas Medicine Announces EDIT-401 Poster Presentation at the American Heart Association (AHA) Scientific Sessions 2025
globenewswire.com
EDIT
Editas Medicine Reports In Vivo Proof-of-Concept Data for EDIT-401 at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress
globenewswire.com
EDIT
Editas Medicine Announces EDIT-401 Oral Presentation at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress and Participation in Upcoming Investor Conferences
globenewswire.com
EDIT